Amelioration of preservation damage but not cyclosporine nephrotoxicity by dihydroergotoxine in kidney transplant recipients. A double-blind placebo-controlled trial

Transplantation. 1989 Nov;48(5):885-6. doi: 10.1097/00007890-198911000-00037.

Authors

M L Brouwer¹, G J Wenting, H H Vincent, G F Hendriks, J Jeekel, W Weimar

Affiliation

¹ Department of Internal Medicine, University Hospital Rotterdam-Dijkzigt, Rotterdam, The Netherlands.

PMID: 2815264
DOI: 10.1097/00007890-198911000-00037

No abstract available

Publication types

Clinical Trial
Controlled Clinical Trial

MeSH terms

Creatine / blood
Cyclosporins / adverse effects
Dihydroergotoxine / therapeutic use*
Double-Blind Method
Humans
Kidney Transplantation*
Organ Preservation

Substances

Cyclosporins
Dihydroergotoxine
Creatine